NRG Therapeutics
Series BCambridge, UKSep 2025
NRG Therapeutics raised €58M in a Series B round in Sep 2025. The company is based in Cambridge, UK. Investors in the round: Brandon Capital, British Business Bank, Criteria Bio Ventures and 4 others. Data as of Nov 2026.
Amount raised
€58M
€57,716,726
Native amount
50,000,000 GBP
Stage
Series B
series b
Investors
7
Provenance & confidence
High confidenceAmount
50,000,000 GBP
ECB-at-date → €58M · rate 0.8663 on 2025-09-09
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
7 namedBrandon CapitalBritish Business BankCriteria Bio VenturesM VenturesNovartis Venture FundOmega FundsSV Health Investors’ Dementia Discovery Fund (DDF)
Date
Sep 2025
Round type
series b
Amount (EUR)
€58M